688073 毕得医药
午间休市 12-19 11:29:30
资讯
新帖
简况
毕得医药涨8.18%,开源证券一个月前给出“买入”评级
证券之星 · 12-18 16:10
毕得医药涨8.18%,开源证券一个月前给出“买入”评级
毕得医药12月17日获主力加仓681万元 环比增加315.24%
市场透视 · 12-17 15:20
毕得医药12月17日获主力加仓681万元 环比增加315.24%
毕得医药(688073)12月16日主力资金净买入194.10万元
证券之星 · 12-17 08:17
毕得医药(688073)12月16日主力资金净买入194.10万元
毕得医药(688073)12月13日主力资金净买入129.72万元
证券之星 · 12-14
毕得医药(688073)12月13日主力资金净买入129.72万元
毕得医药董事、副总经理兼核心技术人员王超辞职
财中社 · 12-13
毕得医药董事、副总经理兼核心技术人员王超辞职
毕得医药(688073.SH):核心技术人员王超辞职
智通财经 · 12-13
毕得医药(688073.SH):核心技术人员王超辞职
毕得医药最新公告:公司董事、副总经理兼核心技术人员王超离职
证券之星 · 12-13
毕得医药最新公告:公司董事、副总经理兼核心技术人员王超离职
毕得医药大涨 近半年多家券商看好
智选洞察 · 12-12
毕得医药大涨 近半年多家券商看好
毕得医药12月11日遭主力抛售382万元 环比增加151.32%
市场透视 · 12-11
毕得医药12月11日遭主力抛售382万元 环比增加151.32%
毕得医药大涨 政策利好支撑
智选洞察 · 12-11
毕得医药大涨 政策利好支撑
毕得医药(688073)12月10日主力资金净卖出241.31万元
证券之星 · 12-11
毕得医药(688073)12月10日主力资金净卖出241.31万元
毕得医药12月09日获主力加仓822万元 环比增加823.60%
市场透视 · 12-09
毕得医药12月09日获主力加仓822万元 环比增加823.60%
毕得医药涨5% 医疗开放政策频出
智选洞察 · 12-09
毕得医药涨5% 医疗开放政策频出
毕得医药上涨 近半年多家券商看好
智选洞察 · 12-06
毕得医药上涨 近半年多家券商看好
毕得医药12月05日主力资金流出304万元 连续5日减仓
市场透视 · 12-05
毕得医药12月05日主力资金流出304万元 连续5日减仓
毕得医药上涨 3券商建议增持
智选洞察 · 12-05
毕得医药上涨 3券商建议增持
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
毕得医药11月26日遭主力抛售343万元 环比增加17050.00%
市场透视 · 11-26
毕得医药11月26日遭主力抛售343万元 环比增加17050.00%
毕得医药大涨 实控人提议回购
智选洞察 · 11-26
毕得医药大涨 实控人提议回购
毕得医药实控人提议公司以0.5亿元至1亿元回购股份
北京商报 · 11-25
毕得医药实控人提议公司以0.5亿元至1亿元回购股份
加载更多
公司概况
公司名称:
上海毕得医药科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-10-11
主营业务:
上海毕得医药科技股份有限公司的主营业务是新药研发机构提供专业、高效的药物分子砌块及科学试剂产品及服务的企业。主要产品为药物分子砌块和科学试剂。公司曾荣获高新技术企业证书,国家级专精特新“小巨人”企业等荣誉。
发行价格:
88.00
{"stockData":{"symbol":"688073","market":"SH","secType":"STK","nameCN":"毕得医药","latestPrice":49.18,"timestamp":1734578970000,"preClose":50.93,"halted":0,"volume":644349,"delay":0,"floatShares":43234200,"shares":90882900,"eps":0.8806,"marketStatus":"午间休市","marketStatusCode":3,"change":-1.75,"latestTime":"12-19 11:29:30","open":50.93,"high":51,"low":48.5,"amount":31807400,"amplitude":0.0491,"askPrice":49.28,"askSize":5,"bidPrice":49.17,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.8806,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734584400000},"adr":0,"adjPreClose":50.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":56.02,"lowLimit":45.84,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":90882948,"pbRate":2.32,"roa":"--","roe":"4.15%","epsLYR":1.21,"committee":0.339806,"marketValue":4470000000,"floatMarketCap":2126000000,"peRate":55.848287,"changeRate":-0.0344,"turnoverRate":0.0149,"status":1},"requestUrl":"/m/hq/s/688073","defaultTab":"news","newsList":[{"id":"2492697943","title":"毕得医药涨8.18%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492697943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492697943?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:10","pubTimestamp":1734509455,"startTime":"0","endTime":"0","summary":"今日毕得医药(688073)涨8.18%,收盘报50.93元。2024年10月24日,开源证券研究员余汝意,聂媛媛发布了对毕得医药的研报《公司信息更新报告:营收平稳增长,盈利能力同环比持续提升》,该研报对毕得医药给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为47.96%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为国联证券的赵雅韵。毕得医药(688073)个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800027078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688073"],"gpt_icon":0},{"id":"2492955344","title":"毕得医药12月17日获主力加仓681万元 环比增加315.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492955344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492955344?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:20","pubTimestamp":1734420017,"startTime":"0","endTime":"0","summary":"12月17日, 毕得医药股价跌2.16%,报收47.08元,成交金额5034万元,换手率2.41%,振幅5.71%,量比0.74。毕得医药今日主力资金净流入681万元,连续3日净流入,上一交易日主力净流入164万元,今日环比增加315.24%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为63.64%,平均涨幅为2.26%。该股近5个交易日上涨3.11%,主力资金累计净流出496万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出687万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153904a1f52ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153904a1f52ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2492673339","title":"毕得医药(688073)12月16日主力资金净买入194.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492673339","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492673339?lang=zh_cn&edition=full","pubTime":"2024-12-17 08:17","pubTimestamp":1734394653,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月16日收盘,毕得医药报收于48.12元,上涨1.97%,换手率1.93%,成交量8362.0手,成交额3980.98万元。12月16日的资金流向数据方面,主力资金净流入194.1万元,占总成交额4.88%,游资资金净流入74.82万元,占总成交额1.88%,散户资金净流出268.92万元,占总成交额6.76%。近5日资金流向一览见下表:毕得医药融资融券信息显示,融资方面,当日融资买入292.34万元,融资偿还390.98万元,融资净偿还98.63万元。毕得医药主营业务:药物分子砌块和科学试剂业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700007801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2491538806","title":"毕得医药(688073)12月13日主力资金净买入129.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491538806","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491538806?lang=zh_cn&edition=full","pubTime":"2024-12-14 08:23","pubTimestamp":1734135830,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月13日收盘,毕得医药报收于47.19元,下跌4.14%,换手率3.14%,成交量1.36万手,成交额6461.37万元。12月13日的资金流向数据方面,主力资金净流入129.72万元,占总成交额2.01%,游资资金净流出142.8万元,占总成交额2.21%,散户资金净流入13.08万元,占总成交额0.2%。近5日资金流向一览见下表:毕得医药融资融券信息显示,融资方面,当日融资买入395.01万元,融资偿还668.24万元,融资净偿还273.23万元。毕得医药主营业务:药物分子砌块和科学试剂业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121400008205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2491013513","title":"毕得医药董事、副总经理兼核心技术人员王超辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2491013513","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491013513?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:18","pubTimestamp":1734085126,"startTime":"0","endTime":"0","summary":"王超因个人原因申请辞职,辞任后不再担任公司任何职务,并将不再被认定为核心技术人员。公告中提到,王超在任职期间所申请的相关专利均为非单一发明人,所有权归属于公司或其子公司,不存在知识产权纠纷或潜在纠纷。王超的离职已经完成工作交接,公司表示其离职不会对公司的持续经营能力、研发实力和核心竞争力产生重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213192957ab752cbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213192957ab752cbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2491826347","title":"毕得医药(688073.SH):核心技术人员王超辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2491826347","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491826347?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:07","pubTimestamp":1734084425,"startTime":"0","endTime":"0","summary":"智通财经APP讯,毕得医药(688073.SH)发布公告,公司董事会于近日收到公司董事、副总经理兼核心技术人员王超先生的辞职报告。王超先生因个人原因申请辞去公司董事、副总经理兼核心技术人员职务,辞任后不再担任公司任何职务,将不再被认定为核心技术人员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2491344007","title":"毕得医药最新公告:公司董事、副总经理兼核心技术人员王超离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2491344007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491344007?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:49","pubTimestamp":1734083392,"startTime":"0","endTime":"0","summary":"毕得医药公告,公司董事会于近日收到董事、副总经理兼核心技术人员王超的辞职报告。王超因个人原因申请辞去公司董事、副总经理兼核心技术人员职务,辞任后不再担任公司任何职务,将不再被认定为核心技术人员。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300033498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2491334602","title":"毕得医药大涨 近半年多家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2491334602","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491334602?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:36","pubTimestamp":1733967363,"startTime":"0","endTime":"0","summary":"12月12日,毕得医药股价大幅上涨,截至09点36分,毕得医药上涨5.21%,报50.30元/股,突破50元整数关口,成交1438万元,换手率0.68%,振幅6.04%。此外,数据统计显示,近半年内3家券商给予增持建议,3家券商给予买入建议。资金动向截止发稿,毕得医药获得主力净流入70万元。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121209361095e91329&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121209361095e91329&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2490386170","title":"毕得医药12月11日遭主力抛售382万元 环比增加151.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490386170","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490386170?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:18","pubTimestamp":1733901538,"startTime":"0","endTime":"0","summary":"12月11日, 毕得医药股价涨4.71%,报收47.81元,成交金额5188万元,换手率2.55%,振幅6.07%,量比0.81。毕得医药今日主力资金净流出382万元,上一交易日主力净流出152万元,今日环比增加151.32%。该股近5个交易日上涨12.02%,主力资金累计净流入75万元;近20日主力资金累计净流出885万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211152848a1e57ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211152848a1e57ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2490704861","title":"毕得医药大涨 政策利好支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2490704861","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490704861?lang=zh_cn&edition=full","pubTime":"2024-12-11 14:25","pubTimestamp":1733898303,"startTime":"0","endTime":"0","summary":"12月11日,毕得医药股价大幅上涨,截至14点25分,毕得医药上涨5.08%,报47.98元/股,成交4656万元,换手率2.29%,振幅5.78%。资金动向截止发稿,毕得医药获得主力净流出339万元,其中超大单流出130万元,大单流出208万元。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121114251795e8df85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121114251795e8df85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2490139079","title":"毕得医药(688073)12月10日主力资金净卖出241.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490139079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490139079?lang=zh_cn&edition=full","pubTime":"2024-12-11 08:21","pubTimestamp":1733876507,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月10日收盘,毕得医药报收于45.66元,下跌2.83%,换手率3.63%,成交量1.57万手,成交额7355.63万元。12月10日的资金流向数据方面,主力资金净流出241.31万元,占总成交额3.28%,游资资金净流出52.23万元,占总成交额0.71%,散户资金净流入293.54万元,占总成交额3.99%。近5日资金流向一览见下表:毕得医药融资融券信息显示,融资方面,当日融资买入848.92万元,融资偿还547.59万元,融资净买入301.33万元。毕得医药主营业务:药物分子砌块和科学试剂业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100007340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2490170417","title":"毕得医药12月09日获主力加仓822万元 环比增加823.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490170417","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490170417?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:21","pubTimestamp":1733728902,"startTime":"0","endTime":"0","summary":"12月09日, 毕得医药股价涨0.23%,报收46.99元,成交金额9955万元,换手率4.69%,振幅9.88%,量比1.97。毕得医药今日主力资金净流入822万元,上一交易日主力净流入89万元,今日环比增加823.60%。该股近5个交易日上涨3.30%,主力资金累计净流入225万元;近20日主力资金累计净流入709万元,其中净流入天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154529a1dfca60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154529a1dfca60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2490679957","title":"毕得医药涨5% 医疗开放政策频出","url":"https://stock-news.laohu8.com/highlight/detail?id=2490679957","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490679957?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707834,"startTime":"0","endTime":"0","summary":"消息解读近期,国家层面在医疗领域推出了一系列扩大开放的政策措施。随后,国家卫生健康委、商务部、国家中医药管理局、国家疾控局四部门又印发《独资医院领域扩大开放试点工作方案》,进一步推动医疗领域的有序开放。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093223971ca683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093223971ca683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","BK0216","688073"],"gpt_icon":0},{"id":"2489147896","title":"毕得医药上涨 近半年多家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2489147896","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489147896?lang=zh_cn&edition=full","pubTime":"2024-12-06 13:01","pubTimestamp":1733461286,"startTime":"0","endTime":"0","summary":"12月06日,毕得医药股价大幅上涨,截至13点01分,毕得医药上涨5.16%,报47.26元/股,成交3035万元,换手率1.53%,振幅6.07%。此外,数据统计显示,近半年内3家券商给予增持建议,3家券商给予买入建议。资金动向截止发稿,毕得医药获得主力净流出7万元,其中超大单流出91万元,大单流入85万元。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120613014398e5c6a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120613014398e5c6a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2489461477","title":"毕得医药12月05日主力资金流出304万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489461477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489461477?lang=zh_cn&edition=full","pubTime":"2024-12-05 15:20","pubTimestamp":1733383250,"startTime":"0","endTime":"0","summary":"12月05日, 毕得医药股价涨5.30%,报收44.94元,成交金额6053万元,换手率3.13%,振幅7.69%,量比1.75。毕得医药今日主力资金净流出304万元,连续5日净流出,上一交易日主力净流出273万元,今日环比增加11.36%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为50.00%,平均跌幅为1.24%。该股近5个交易日下跌0.90%,主力资金累计净流出888万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出2436万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205153803a1d5b88e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205153803a1d5b88e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2489946424","title":"毕得医药上涨 3券商建议增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2489946424","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489946424?lang=zh_cn&edition=full","pubTime":"2024-12-05 11:00","pubTimestamp":1733367655,"startTime":"0","endTime":"0","summary":"12月05日,毕得医药股价大幅上涨,截至11点00分,毕得医药上涨5.04%,报44.83元/股,成交2383万元,换手率1.25%,振幅5.11%。此外,数据统计显示,近半年内3家券商给予增持建议,3家券商给予买入建议。资金动向截止发稿,毕得医药获得主力净流入68万元。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205110118a1d53013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205110118a1d53013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486287410","title":"毕得医药11月26日遭主力抛售343万元 环比增加17050.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486287410","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486287410?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:22","pubTimestamp":1732605751,"startTime":"0","endTime":"0","summary":"11月26日, 毕得医药股价涨4.68%,报收45.00元,成交金额7653万元,换手率3.89%,振幅8.14%,量比1.35。毕得医药今日主力资金净流出343万元,连续4日净流出,上一交易日主力净流出2万元,今日环比增加17050.00%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为33.33%,平均跌幅为2.93%。该股近5个交易日上涨5.39%,主力资金累计净流出174万元;近20日主力资金累计净流出7607万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126154031a2567263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126154031a2567263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2486094433","title":"毕得医药大涨 实控人提议回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2486094433","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486094433?lang=zh_cn&edition=full","pubTime":"2024-11-26 09:36","pubTimestamp":1732584974,"startTime":"0","endTime":"0","summary":"11月26日,毕得医药股价大幅上涨,截至09点36分,毕得医药上涨5.14%,报45.20元/股,成交686万元,换手率0.36%,振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份,此举基于对公司未来发展的信心和对公司价值的认可。资金动向截止发稿,毕得医药获得主力净流入65万元。最新财报显示,今年三季报,毕得医药实现营业收入8.11亿元,同比增长0.79%,净利润为8,385.39万元,同比减少26.05%,基本每股收益为0.94元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2486090677","title":"毕得医药实控人提议公司以0.5亿元至1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486090677","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486090677?lang=zh_cn&edition=full","pubTime":"2024-11-25 18:08","pubTimestamp":1732529318,"startTime":"0","endTime":"0","summary":"北京商报讯 11月25日晚间,毕得医药发布公告称,公司实际控制人、董事长、总经理戴岚提议公司通过上交所交易系统以集中竞价交易方式回购公司已发行的部分人民币普通股(A股)股票,回购资金总额不低于0.5亿元(含),不超过1亿元(含)。文章来源:北京商报文章作者:丁宁毕得医药实控人提议公司以0.5亿元至1亿元回购股份","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125182958abdd8106&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125182958abdd8106&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-10-11","address":"上海市杨浦区翔殷路128号11号楼A座101室","stockEarnings":[{"period":"1week","weight":0.0653},{"period":"1month","weight":0.1955},{"period":"3month","weight":0.7022},{"period":"6month","weight":0.6335},{"period":"1year","weight":-0.0171},{"period":"ytd","weight":-0.0546}],"companyName":"上海毕得医药科技股份有限公司","boardCode":"AI0073","perCapita":"10516股","boardName":"研究和试验发展","registeredCapital":"9088万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":" 上海毕得医药科技股份有限公司的主营业务是新药研发机构提供专业、高效的药物分子砌块及科学试剂产品及服务的企业。主要产品为药物分子砌块和科学试剂。公司曾荣获高新技术企业证书,国家级专精特新“小巨人”企业等荣誉。","serverTime":1734580506458,"listedPrice":88,"stockholders":"4111人(较上一季度减少5.25%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"毕得医药,688073,毕得医药股票,毕得医药股票老虎,毕得医药股票老虎国际,毕得医药行情,毕得医药股票行情,毕得医药股价,毕得医药股市,毕得医药股票价格,毕得医药股票交易,毕得医药股票购买,毕得医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}